Chromosome 7q deletions: observations on 13 malignant tumors, Cancer Genet Cytogenet, vol.67, pp.123-125, 1993. ,
DOI : 10.1016/0165-4608(93)90164-h
The effect of human tissue factor pathway inhibitor-2 on the growth and metastasis of fibrosarcoma tumors in athymic mice, Blood, vol.103, pp.1069-1077, 2004. ,
The plasmin cascade and matrix metalloproteinases in non-small cell lung cancer, Thorax, vol.54, pp.169-179, 1999. ,
New functions for the matrix metalloproteinases in cancer progression, Nat Rev Cancer, vol.2, pp.161-174, 2002. ,
Inactivation of the DNA repair gene O6-methylguanine-DNA methyltransferase by promoter hypermethylation is a common event in primary human neoplasia, Cancer Res, vol.59, pp.793-797, 1999. ,
The case for early detection, Nat Rev Cancer, vol.3, pp.243-252, 2003. ,
DNA methylation: a profile of methods and applications, Biotechniques, vol.33, pp.636-649, 2002. ,
Gene silencing in cancer in association with promoter hypermethylation, N Engl J Med, vol.349, pp.2042-2054, 2003. ,
Characterization and functional analysis of TFPI-2 gene promoter in a human choriocarcinoma cell line, Thromb Res, vol.109, pp.207-215, 2003. ,
URL : https://hal.archives-ouvertes.fr/hal-02127781
Transcriptional silencing of the TFPI-2 gene by promoter hypermethylation in choriocarcinoma cells, Biol Chem, vol.384, pp.1029-1034, 2003. ,
URL : https://hal.archives-ouvertes.fr/hal-02127398
Demonstration of a tissue factor pathway inhibitor 2 messenger RNA synthesis by pure villous cytotrophoblast cells isolated from term human placentas, Biol Reprod, vol.68, pp.1888-1894, 2003. ,
URL : https://hal.archives-ouvertes.fr/hal-02127745
Fast detection of tissue factor and tissue factor pathway inhibitor messenger RNA in endothelial cells and monocytes by sensitive reverse transcription-polymerase chain reaction, Thromb Res, vol.94, pp.165-173, 1999. ,
Demonstration of inducible TFPI-2 mRNA synthesis in BeWo and JEG-3 trophoblast cells using a competitive RT-PCR, Thromb Res, vol.105, pp.217-223, 2002. ,
URL : https://hal.archives-ouvertes.fr/hal-02127753
Tissue factor pathway inhibitor-2 suppresses the production of active matrix metalloproteinase-2 and is down-regulated in cells harboring activated ras oncogenes, FEBS Lett, vol.481, pp.31-36, 2000. ,
The ERK/MAPK pathway regulates the activity of the human tissue factor pathway inhibitor-2 promoter, J Biol Chem, vol.278, pp.6787-6794, 2003. ,
Promoter methylation and silencing of the tissue factor pathway inhibitor-2 (TFPI-2), a gene encoding an inhibitor of matrix metalloproteinases in human glioma cells, Oncogene, vol.22, pp.4509-4516, 2003. ,
Role of tissue factor pathway inhibitor-2 (TFPI-2) in amelanotic melanoma (C-32) invasion, Clin Exp Metast, vol.18, pp.303-308, 2000. ,
Overexpression of tissue factor pathway inhibitor-2 (TFPI-2), decreases the invasiveness of prostate cancer cells in vitro, Int J Oncol, vol.18, pp.127-131, 2001. ,
In vitro modulation of human lung cancer cell line invasiveness by antisense cDNA of tissue factor pathway inhibitor-2, Clin Exp Metast, vol.18, pp.239-244, 2000. ,
Assignment of the human PP5/TFPI-2 gene to 7q22 by FISH and PCR-based human/rodent cell hybrid mapping panel analysis, Genomics, vol.35, pp.267-268, 1996. ,
Revisions in the International System for staging lung cancer, Chest, vol.111, pp.1710-1717, 1997. ,
Genomic imbalances in human lung adenocarcinomas and squamous cell carcinomas, Genes Chromosomes Cancer, vol.31, pp.282-287, 2001. ,
Expression of tissue factor pathway inhibitor 2 inversely correlates during the progression of human gliomas, Clin Cancer Res, vol.7, pp.570-576, 2001. ,
Regulation of ProMMP-1 and ProMMP-3 activation by tissue factor pathway inhibitor-2/matrixassociated serine protease inhibitor, Biochem Biophys Res Commun, vol.255, pp.94-98, 1999. ,
Extracellular matrix-associated serine protease inhibitors (Mr 33,000, 31,000, and 27,000) are single-gene products with differential glycosylation: cDNA cloning of the 33-kDa inhibitor reveals its identity to tissue factor pathway inhibitor-2, Arch Biochem Biophys, vol.335, pp.82-92, 1996. ,
Prokaryotic expression, purification, and reconstitution of biological activities (antiprotease, antitumor, and heparin-binding) for tissue factor pathway inhibitor-2, Biochem Biophys Res Commun, vol.276, pp.1286-1294, 2000. ,
Methylation of TFPI-2 gene is not the sole cause of its silencing, Int J Oncol, vol.22, pp.843-848, 2003. ,
Hypermethylation of the death-associated protein (DAP) kinase promoter and aggressiveness in stage I non-small-cell lung cancer, J Natl Cancer Inst, vol.92, pp.1511-1516, 2000. ,
A novel role of tissue factor pathway inhibitor-2 in apoptosis of malignant human gliomas, Int J Oncol, vol.19, pp.591-597, 2001. ,
World Health Organization Classification of Lung and Pleural Tumors, 1999. ,
Epigenetic gene silencing in cancer, J Clin Invest, vol.105, pp.401-407, 2000. ,
Novel candidate tumor marker genes for lung adenocarcinoma, Oncogene, vol.21, pp.7598-7604, 2002. ,
Immunohistochemical localization of tissue factor pathway inhibitor-2 in human tumor tissue, Thromb Haemost, vol.90, pp.140-146, 2003. ,
Promoter hypermethylation of tumor suppressor and tumor-related genes in non-small cell lung cancers, Cancer Sci, vol.94, pp.589-592, 2003. ,
Molecular pathogenesis of lung cancer, Annu Rev Physiol, vol.64, pp.681-708, 2002. ,